Embla Medical hf. (OSSFF)

Market Cap	1.74B
Revenue (ttm)	854.89M
Net Income (ttm)	68.28M
Shares Out	n/a
EPS (ttm)	0.16
PE Ratio	25.44
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	120
Average Volume	10,321
Open	4.150
Previous Close	4.080
Day's Range	4.150 - 4.150
52-Week Range	4.080 - 5.180
Beta	0.57
RSI	39.62
Earnings Date	Apr 29, 2025

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. Its Bracing and Supports segment provides bracing and...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1971
• Employees: 4,061
• Stock Exchange: OTCMKTS
• Ticker Symbol: OSSFF

Financial Performance

In 2024, Embla Medical's revenue was $854.89 million, an increase of 8.81% compared to the previous year's $785.68 million. Earnings were $68.28 million, an increase of 16.94%.